Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1986 Jun 1;134(11):1259–1261.

The experience and effectiveness of the Nova Scotia Rh program, 1964-84.

T F Baskett, M L Parsons, L J Peddle
PMCID: PMC1491101  PMID: 3011235

Abstract

A program to reduce the incidence of erythroblastosis fetalis was started in Nova Scotia in 1964. Up to the end of 1984, 120 fetuses received 247 intrauterine transfusions. The survival rate was 45.6% in the first 10 years of the program and 66.7% in the next 11 years. For fetuses at or over 26 weeks' gestation the figures were 51.5% and 73.7% respectively. Postpartum prevention was started in 1968, with administration of Rh immune globulin (RhIG) to Rh-negative unimmunized women within 72 hours after the birth of an Rh-positive infant. Antepartum prevention, started in 1979, consisted of administration of RhIG at 28 weeks' gestation to Rh-negative unimmunized women. The effectiveness of the prevention program was evaluated by enumerating the known cases of Rh(D) alloimmunization in the province from 1982 to 1984: 55 cases were identified, a rate of 1.5 per 1000 births instead of the expected rate of about 10 per 1000.

Full text

PDF
1259

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berkowitz R. L. Intrauterine transfusion, 1980: an update. Clin Perinatol. 1980 Sep;7(2):285–297. [PubMed] [Google Scholar]
  2. Bowman J. M., Chown B., Lewis M., Pollock J. Rh isoimmunization, Manitoba, 1963-75. Can Med Assoc J. 1977 Feb 5;116(3):282–284. [PMC free article] [PubMed] [Google Scholar]
  3. Bowman J. M., Manning F. A. Intrauterine fetal transfusions: Winnipeg 1982. Obstet Gynecol. 1983 Feb;61(2):203–209. [PubMed] [Google Scholar]
  4. Bowman J. M., Pollock J. Rh immunization in Manitoba: progress in prevention and management. Can Med Assoc J. 1983 Aug 15;129(4):343–345. [PMC free article] [PubMed] [Google Scholar]
  5. Bowman J. M. The management of Rh-Isoimmunization. Obstet Gynecol. 1978 Jul;52(1):1–16. [PubMed] [Google Scholar]
  6. Cooperberg P. L., Carpenter C. W. Ultrasound as an aid in intrauterine transfusion. Am J Obstet Gynecol. 1977 Jun 1;128(3):239–241. doi: 10.1016/0002-9378(77)90615-9. [DOI] [PubMed] [Google Scholar]
  7. Corston J. M., Pereira E., Cudmore D. W., Morton B. S. Five years' experience with intrauterine transfusion. Can Med Assoc J. 1970 Sep 26;103(6):594–599. [PMC free article] [PubMed] [Google Scholar]
  8. Frigoletto F. D., Jr, Umansky I., Birnholz J., Acker D., Easterday C. L., Harris G. B., Griscom N. T. Intrauterine fetal transfusion in 365 fetuses during fifteen years. Am J Obstet Gynecol. 1981 Apr 1;139(7):781–790. doi: 10.1016/0002-9378(81)90543-3. [DOI] [PubMed] [Google Scholar]
  9. Harman C. R., Manning F. A., Bowman J. M., Lange I. R. Severe Rh disease--poor outcome is not inevitable. Am J Obstet Gynecol. 1983 Apr 1;145(7):823–829. doi: 10.1016/0002-9378(83)90686-5. [DOI] [PubMed] [Google Scholar]
  10. Kelton J. G. Eradication of Rh hemolytic disease of the newborn. Can Med Assoc J. 1980 Dec 6;123(11):1089–1091. [PMC free article] [PubMed] [Google Scholar]
  11. Rodeck C. H., Nicolaides K. H., Warsof S. L., Fysh W. J., Gamsu H. R., Kemp J. R. The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions. Am J Obstet Gynecol. 1984 Nov 15;150(6):769–774. doi: 10.1016/0002-9378(84)90683-5. [DOI] [PubMed] [Google Scholar]
  12. Urbaniak S. J. Rh(D) haemolytic disease of the newborn: the changing scene. Br Med J (Clin Res Ed) 1985 Jul 6;291(6487):4–6. doi: 10.1136/bmj.291.6487.4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES